Scientific & Medical Advisory Council

The Scientific and Medical Advisory Council (SMAC) provides the collective voice and leadership for the Crohn’s and Colitis Canada IBD Research Institute (IBDRI).

Crohn’s and Colitis Canada relies on guidance from this group of experts as it strives to deliver on its mission to find the cures for Crohn's disease and ulcerative coitis and improve the lives of children and adults affected by these diseases.

The 2015/2016 SMAC includes:

Name Position Institution  

Dr. Mark Silverberg

Chair

Mount Sinai Hospital

Current

Dr. John Rioux

Vice-Chair

Université de Montréal + Montreal Heart Institute

2013-2014

Dr. Stephen Vanner

Research Chair

Queen's University + Kingston General Hospital

2013-2015

Dr. John Marshall

Associate Chair Research

McMaster University Medical Centre

2011-2014

Dr. Tony Otley

Chair Research Communications

Dalhousie University + IWK Health Centre

2011-2014

Dr. Laura Sly

Member-at-large

Child & Family Research Institute

2011-2014

Dr. Subrata Gosh

Advocacy Chair

University of Calgary

2011-2014

Dr. Tony Otley

Chair Research Communications

Dalhousie University

2011-2014

Dr. Laura Sly

Member-at-large

University of British Colombia

2011-2014

Dr. Elaine Petrof

Member-at-large

Queen's University

2011-2014

Dr. Charlie Lees

Member-at-large

University of Edinburgh

2013-2016

Dr. Gill Kaplan

Member-at-large

University of Calgary

2013-2016

Aida Fernandes

VP, Research and Patient Programs

Crohn’s and Colitis Canada

Ongoing

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 150 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest